DT
CTKB icon

Diversified Trust’s Cytek Biosciences CTKB Stock Holding History

Diversified Trust’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-24,532
Closed -$83.4K – 1014
2025
Q2 		$83.4K Hold
24,532
– – ﹤0.01% 912
2025
Q1 		$98.4K Buy
+24,532
New +$127K ﹤0.01% 893

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Diversified Trust's CTKB Position: Q3 2025 in Review

Diversified Trust sold out of Cytek Biosciences (CTKB) in Q3 2025, closing a stake of 24,532 shares — an estimated $83.4K sold.

Diversified Trust first reported a position in CTKB in Q1 2025 and held it in 2 quarters. The position peaked at $98.4K in Q1 2025. 153 funds tracked by Wall St. Rank hold CTKB as of Q3 2025.

  • Diversified Trust reported no remaining Cytek Biosciences position as of Q3 2025 after selling out during the quarter.
  • Diversified Trust sold 24,532 Cytek Biosciences shares in Q3 2025, an estimated $83.4K.
  • Diversified Trust first reported a position in Cytek Biosciences in Q1 2025 and held it in 2 quarters.
  • Diversified Trust's Cytek Biosciences position peaked at $98.4K in Q1 2025.
  • 153 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2025.

Based on Diversified Trust's 13F filing for Q3 2025, filed 20 Oct 2025.